This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Propranolol

Extensively Studied

Cheap, generic, non-selective beta-blocker that shuts off the peripheral adrenergic symptoms of stage fright (racing heart, tremor, sweat,…

Aliases (6)
Inderal · Inderal LA · InnoPran XL · Hemangeol · Bedranol · Avlocardyl
TYPICAL DOSE
20 mg
BID-QID
ROUTE
Oral (tablet)
Oral
CYCLE
none — PRN as needed, no cycling protocol
As prescribed
STORAGE
Room temp; original container
Room temp

Overview

What is Propranolol?

Propranolol is a non-selective β-adrenergic receptor antagonist (β-blocker), the first beta blocker discovered (Black, 1962, Nobel 1988). It is FDA-approved for hypertension, angina, post-MI, arrhythmias, migraine prophylaxis, essential tremor, hypertrophic subaortic stenosis, and pheochromocytoma.

Key Benefits

Beyond cardiovascular indications, widely used off-label for performance anxiety, social anxiety symptoms (tremor, palpitations), PTSD-related memory reconsolidation, and akathisia. Reduces somatic symptoms of acute anxiety without sedation or cognitive impairment.

Mechanism of Action

Competitively blocks β1 (cardiac) and β2 (vascular, bronchial) adrenergic receptors, reducing heart rate, contractility, and cardiac output, and inhibiting renin release. Crosses the BBB to dampen central noradrenergic signaling underlying anxiety symptoms and memory reconsolidation.

Pharmacokinetics

·
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK
Brand options6 known
InderalInderal LAInnoPran XLHemangeolBedranolAvlocardyl

StatusPrescription-only (US, EU, UK, AU, CA); not DEA-scheduled

Peptide Interactions

l-theanine 200 mg:
Synergistic

Co-administer at the same time for an additive layer of calm. L-theanine acts on the GABA/glutamate axis (some α-wave / mild GABA-A modulation, glutamate buf…

practice + structured pre-event routine.
Synergistic

Propranolol works best as a backstop for a well-rehearsed, well-prepared event. It doesn't substitute for prep — it lets your prep show through without somat…

breath-work / box breathing pre-event.
Synergistic

Vagal-tone shift adds to the parasympathetic effect.

armodafinil same-day (this archetype's typical stack flag):
Avoid

Armodafinil is a moderate CYP2C19 inhibitor and a weak CYP1A2 inducer. Propranolol is metabolized via CYP2D6 (primary) and CYP1A2 + CYP2C19 (secondary). Net …

modafinil same-day:
Avoid

Same logic, slightly weaker effect. Same dose-down rule advisable.

other beta-blockers
Avoid

redundant.

calcium channel blockers (verapamil, diltiazem)
Avoid

additive bradycardia and AV-conduction depression. Not relevant for users in this archetype but a hospital-emergency-department flag.

clonidine
Avoid

additive bradycardia and rebound-hypertension complication if either is withdrawn. Not relevant.

MAOIs
Avoid

theoretical risk, rare clinical issue.

ergot alkaloids
Avoid

peripheral vasoconstriction additive.

insulin/sulfonylureas
Avoid

(not relevant to the user) — masks hypoglycemia symptoms.

alcohol heavy use same-day
Avoid

additive hypotension; mild. Not relevant for users in this archetype (zero alcohol).

Quality Indicators

Pharmacy-dispensed, intact packaging

Prescription tablets in original sealed packaging from a licensed pharmacy.

!

Generic vs branded

Generics are usually fine but bioavailability can vary slightly; track if you switch.

Unbranded blister or counterfeit risk

Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.

What to Expect

  • Day 1
    PK-driven acute peak per administration. Verify dose tolerated.
  • Week 1
    Steady-state reached for most daily-dosed pharma.
  • Week 2-4
    Therapeutic effect established; titration window if needed.
  • Long-term
    Periodic monitoring per drug class (labs, BP, ECG as applicable).

Side Effects & Safety 8

Side Effects

  1. 1Bradycardia / low pulse — expected pharmacodynamic effect. At PRN 20 mg in a healthy 20-year-old, HR drop is ~5-15 bpm. If resting HR is already <50 bpm, dose down or skip.
  2. 2Cold extremities — reduced peripheral perfusion. Hands/feet feel cold or tingly. Usually mild and self-limiting.
  3. 3Mild fatigue / lethargy at higher chronic doses (uncommon at PRN doses).
  4. 4Dizziness / lightheadedness — usually positional; resolves with hydration and avoiding rapid postural change.
  5. 5Nausea / GI upset — take with food.
  6. 6Bronchospasm — relevant to anyone with asthma history. Propranolol's β2 blockade can trigger bronchoconstriction. Asthmatics should use β1-selective alternatives (metoprolol, atenolol) instead, or avoid beta-blockers entirely.
  7. 7Vivid dreams / nightmares — small minority of chronic users report this. Mechanism unclear (possibly REM-architecture effects from CNS penetration). Rare at PRN dosing.
  8. 8Erectile dysfunction at chronic dose — uncommon; not relevant to PRN single-event use.

When to Stop

  • Severe bradycardia or AV block — particularly relevant if the user has pre-existing conduction disease. ECG screening before chronic use, not before a single PRN trial dose.
  • Bronchospasm in undiagnosed asthma — first-dose risk. The reason for a low-stakes test dose first.
  • Hypoglycemia masking — propranolol blunts the adrenergic warning signs of low blood sugar (tachycardia, tremor) so a hypoglycemic episode can become severe before being recognized. Relevant for diabetics on insulin/sulfonylureas. Not relevant for users in this archetype.
  • Withdrawal rebound — abrupt cessation after chronic high-dose use can produce rebound tachycardia, hypertension, and (theoretically) MI in cardiac patients. Not relevant to PRN use; relevant if the user ever migrates to chronic dosing.
  • Depression / psychiatric effects — older literature suggested chronic high-dose propranolol increases depression risk. More recent meta-analyses (Riemer et al. 2021) show minimal-to-no effect on mood in non-cardiac populations. Probably an over-stated risk; still worth knowing.
  • First test dose: confirm no bronchospasm, no excessive bradycardia. Have a plan to abort if the response is unexpected (rest, hydrate, wait it out — propranolol is competitively reversible and short-half-life).
  • First training/cardio day after exposure — verify the workout feel. If you tested propranolol on a Friday evening and your Saturday morning training feels notably worse, that's a sign the half-life carried over more than expected; space the next dose further from cardio events.
  • Max HR cap. β1 blockade prevents the heart from achieving full sympathetic-driven max HR. For aerobic athletes, this cuts ~15-30 bpm off max HR and proportionally reduces cardiac output and VO2max during the dose window. For MMA conditioning (rounds, training, intervals), this is a real performance hit — you'll feel like the gas tank is half-size.
  • Lactate clearance. Less well-characterized but β2 blockade impairs muscle glycogenolysis and possibly fat mobilization, which can shorten time-to-fatigue at moderate-to-high intensity.
  • Thermoregulation. Reduced peripheral blood flow under propranolol = slightly impaired heat dissipation in hot training environments.
  • Practical rule for users in this archetype: do not dose propranolol on any day with cardio training, hard pad work, or interval conditioning. PRN propranolol is compatible with technical drilling / light flow / rolling, not with full-output conditioning.

References

Brantigan, Brantigan & Joseph 1982 — Effect of beta-blockade on stage fright (American Journal of Medicine)

pubmed.ncbi.nlm.nih.gov · 1982

classical RCT, 29 musicians; propranolol improves performance + reduces somatic symptoms

View Study

Brunet et al. 2008 — Effect of post-retrieval propranolol on PTSD reactions (J Psychiatr Res)

pubmed.ncbi.nlm.nih.gov · 2008

original reconsolidation protocol

View Study

Brunet et al. 2018 — Reduction of PTSD symptoms with propranolol-induced reconsolidation blockade RCT (Am J Psychiatry)

pubmed.ncbi.nlm.nih.gov · 2018

n=60 chronic PTSD, large effect size, sustained at 4-month follow-up

View Study

Roullet et al. 2021 — Reactivation under propranolol meta-analysis

pubmed.ncbi.nlm.nih.gov · 2021

pooled reconsolidation literature

View Study

Soeter & Kindt 2015 — Disrupting reconsolidation: pharmacological and behavioral manipulations (Biological Psychiatry)

pubmed.ncbi.nlm.nih.gov · 2015

phobia reconsolidation work

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Propranolol

More in Pharmaceutical · Oral

94 compounds in bucket